A Korean biotech called GC has applied for an investigational new drug application (IND) to conduct a Phase 2 clinical trial for a COVID-19 plasma…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.